MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer.
- Published in:
- Drug Development Research, 2015, v. 76, n. 6, p. 328, doi. 10.1002/ddr.21270
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2015 AND VI 76 AND IP 6
Results: 8
1
2
The Role of miR-21 in Cancer.
- Published in:
- Drug Development Research, 2015, v. 76, n. 6, p. 270, doi. 10.1002/ddr.21257
- By:
- Publication type:
- Article
3
Exosomal MicroRNAs in Tissue Crosstalk.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
4
miRNAs as Biomarkers in Chronic Myelogenous Leukemia.
- Published in:
- Drug Development Research, 2015, v. 76, n. 6, p. 278, doi. 10.1002/ddr.21266
- By:
- Publication type:
- Article
5
A New Role for an Old Drug: Metformin Targets Micro RNAs in Treating Diabetes and Cancer.
- Published in:
- Drug Development Research, 2015, v. 76, n. 6, p. 263, doi. 10.1002/ddr.21265
- By:
- Publication type:
- Article
6
MicroRNA Regulation of Airway Inflammation and Airway Smooth Muscle Function: Relevance to Asthma.
- Published in:
- Drug Development Research, 2015, v. 76, n. 6, p. 286, doi. 10.1002/ddr.21267
- By:
- Publication type:
- Article
7
Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.
- Published in:
- Drug Development Research, 2015, v. 76, n. 6, p. 296, doi. 10.1002/ddr.21268
- By:
- Publication type:
- Article
8
MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.
- Published in:
- Drug Development Research, 2015, v. 76, n. 6, p. 318, doi. 10.1002/ddr.21269
- By:
- Publication type:
- Article